Sunshine Guojian Pharmaceutical(SH:688336) Zheng Quan Shi Bao·2025-05-22 13:49Market Overview - On May 22, major market indices collectively retreated, with a total trading volume of 1.14 trillion yuan, a decrease of 74.7 billion yuan compared to the previous day [1] - The number of stocks that rose was less than 900, while nearly 4,500 stocks declined, with 51 stocks hitting the daily limit up and 18 stocks hitting the daily limit down [1] - Industry sectors experienced widespread declines, with beauty care, social services, and basic chemicals dropping over 1.5%, while only banking, media, and household appliances saw gains [1] Stockholder Changes - A total of 365 stocks reported changes in shareholder numbers as of May 20, with 170 stocks seeing a decrease in shareholder accounts compared to May 10 [2] - The stock with the largest decline in shareholder accounts was Shanshui Bide, which saw a 33.18% drop to 4,909 accounts [2] - Ji Qi Co., Ltd. also reported a significant decrease of 15.50% in shareholder accounts, totaling 17,413 [2] Institutional Trading - On May 22, 10 stocks saw net purchases from institutions, with Tianqi Mould and Aerospace Nanhu receiving over 50 million yuan in net buying [3] - The stock San Sheng Guo Jian faced the largest net selling from institutions, amounting to 151 million yuan, following a 100% increase in price over four consecutive days of hitting the daily limit up [3][4] - The institutional trading data indicates a trend of increasing net selling for San Sheng Guo Jian over three consecutive days [3] Northbound Capital Flow - On May 22, seven stocks experienced net buying from northbound funds, with San Sheng Guo Jian leading at 35.03 million yuan [5] - The stock Lianyun Port saw the highest net selling from northbound funds, totaling 51.66 million yuan [5] Important Announcements - Chao Da Equipment was selected for the 2025 Jiangsu Province Advanced Intelligent Factory list for its smart collaborative manufacturing project [6] - Bo Rui Pharmaceutical received a drug registration certificate for Iopamidol injection from the National Medical Products Administration [6] - Chengdu Xian Dao's shareholder plans to increase its stake in the company by 25 to 50 million yuan without a set price range [6] - Xinhua Insurance signed a contract to establish a private equity fund with a total scale of 20 billion yuan, contributing 10 billion yuan [6] - Zhongnan Media's subsidiary signed a government procurement contract worth 1.009 billion yuan, positively impacting the company's operations in 2025 [6]